Official position
Physician-in-Chief, Psychiatric Hospital and Outpatient Clinics, Elblandklinikum Radebeul
Head of outpatient Center for Addictive Disorders, Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus
Institution
Elblandklinikum Radebeul, Academic teaching-hospital of the Technische Universität Dresden, Dresden, Germany
Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
Business address
Fetscherstraße 74
01307 Dresden
Academic education and degrees
1997 - 2001 | Medicine, Medical School, Rheinische Friedrich-Wilhelms-Universität, Bonn |
2001 - 2005 | Medicine, Medical School, Charité Berlin, MD 2005 |
2011 | Dissertation, TU Dresden (thesis advisor: Prof. Dr. Dr. Michael Bauer) |
2016 | Habilitation, Postdoctoral lecture qualification (venia legendi) in Psychiatry TU Dresden |
Professional career
2005 - 2006 | Residency in Psychiatry and Psychotherapy, Charité Berlin, Germany |
2007 - 2013 | Residency in Psychiatry and Psychotherapy, TU Dresden, Germany |
2011 - 2013 | Postdoctoral researcher, Neuroimaging Center, TU Dresden |
2013 - 2018 | Attending physician (Oberarzt), Dept. of Psychiatry and Psychotherapy, University Hospital, TU Dresden |
2018 - 2020 | Head of Clinical Center for Addictive Disorders,
Dept. of Psychiatry and Psychotherapy, University Hospital, TU Dresden |
Since 2020 | Physician-in-Chief, Psychiatric Hospital and Outpatient Clinics, Elblandklinikum Radebeul (Academic teaching-hospital of the Technische Universität Dresden) |
Since 2020 | Head of Outpatient Center for Addictive Disorders,
Dept. of Psychiatry and Psychotherapy, University Hospital, TU Dresden |
Honors, awards and positions
1996 | A-levels with top marks (1,0) |
2011 | Medical doctor thesis work with “summa cum laude” |
2013 | Selection for “Hot Topics book” of the SfN 2013 |
2013 | Travel Grant (DAAD) SfN / San Diego |
2017 | Posterpreis „Mitteldeutsche Psychiatrietage“ |
2017 | “MeDDrive” Grant, TU Dresden |
Since 2019 | Project leader, Collaborative Research Centre TRR 265: Losing and Regaining Control over Drug Intake, DFG |
Since 2014 | Member International Group for the Study of Lithium-Treated Patients (IGSLI) |
Current Journal Editorial positions
Since 2018 | Guest Editor, Frontiers in Psychiatry |
10 most important peer-reviewed papers (10 out of 51, Scopus h-index: 18)
Bernhardt N, Petzold J, Groß C, Scheck A, Pooseh S …
Pilhatsch M. Neurocognitive Dysfunctions and their Therapeutic Modulation in Patients with Methamphetamine Dependence: A Pilot Study. Front Psychiatry. 2020;11:581.
Petzold J, Weber B, Bassett TR, Bauer M, Bernhardt N …
Pilhatsch M. Effectiveness of the First German-Language Group Psychotherapy Manual to Accompany Short-Term Treatment in Methamphetamine Dependence. Front Psychiatry. 2020;11:130.
Kohno M, Beste C,
Pilhatsch M. Editorial: The Global Methamphetamine Problem: Approaches to Elucidate the Neurobiology, Epidemiology, and Therapeutic Effectiveness. Front Psychiatry. 2020;11:850.
Pilhatsch M, J Stamm T, Stahl P, Lewitzka U, Berghöfer A et al. Treatment of bipolar depression with supraphysiologic doses of levothyroxine: a randomized, placebo-controlled study of comorbid anxiety symptoms. Int J Bipolar Disord. 2019;7(1):21.
Pilhatsch M, Berghöfer A, Mayer-Pelinski R, Berghöfer G, Ricken R et al. Long-term treatment with supraphysiologic doses of levothyroxine in treatment-refractory mood disorders – a prospective study of cardiovascular tolerability. J Affective Disorders. 2018;238:213-217.
Pilhatsch M, Glenn T, Rasgon N, Alda M, Sagduyu K et al. Regularity of self-reported daily dosage of mood stabilizers and antipsychotics in patients with bipolar disorder. International Journal of Bipolar Disorders. 2018;6(1):1-9.
Pilhatsch M, Vetter NC, Hübner T, Ripke S, Müller KU et al. Amygdala-function perturbations in healthy mid-adolescents with familial liability for depression. Journal of the American Academy of Child and Adolescent Psychiatry. 2014;53(5):559-68.
Pilhatsch M, Schlagenhauf F, Silverman DH, Berman SM, London ED et al. Antibodies in autoimmune thyroiditis affect glucose metabolism of anterior cingulate. Brain, Behavior & Immunity. 2014;37:73-7.
Pilhatsch M, Wolf R, Schön S, Bauer M. Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomised, double-blind study. J Affective Disorders. 2010;126(3):453-7.
Pilhatsch M, Winter C, Nordström K, Vennström B, Bauer M, Juckel G. Increased learned helplessness in mice harboring the mutant thyroid hormone receptor alpha 1. Behavioral Brain research. 2010;214(2):187-92.
Foto: Elblandklinikum Radebeul
